The DDW meeting 2023 covered a huge variety of basic, translational and clinical aspects of research in gastrointestinal and extraintestinal human health and disease. This post highlights the major-takeaways from the Microbiome & Microbial Therapy sessions and unravels how they might impact daily basic research and clinical practice (part 1).
Author: Abhay Panchal
A process improvement project at one endoscopy center has identified a consistent delay in inpatient procedural start times as a culprit for reduced patient throughput. The project, presented at 2023 Canadian Digestive Diseases Week 2023, looked at maximizing endoscopy unit efficiency over a period of 12 months by adding one completed procedure per day. “It wasn’t that we needed more resources,” said lead researcher Mayur Brahmania, MD, MPH, a gastroenterologist/hepatologist and an assistant professor of medicine at the University of Western Ontario, in London, Ontario. “It was that we needed to better utilize the time we already had.”
Small Talk, Big Topics host Dr. Matthew Whitson is joined by Drs. Renumathy Dhanasekaran, Alexandra T. Strauss and Daniel Penrice for a conversation about the rise of artificial intelligence (AI) and how it will impact gastroenterology and the medical field. Dr. Dhanasekaran is an assistant professor at Stanford University, Dr. Strauss is an assistant professor at Johns Hopkins University and Dr. Penrice is a gastroenterology fellow at the Mayo Clinic in Rochester, Minnesota.
Key takeaways: Computer-aided detection in colonoscopy had a “positive effect” on adenoma detection rate, mean number of adenomas per colonoscopy and polyp detection rate and should be considered when performing routine colonoscopy, researchers reported.
NEW YORK CITY, NY, UNITED STATES, June 28, 2023/EINPresswire.com/ — The global Capsule Endoscopy Market was valued at USD 507.5 million in 2021 and is projected to experience a compound annual growth rate (CAGR) of 8.8% during the forecast period. The main drivers of market revenue growth include the increasing prevalence of gastrointestinal disorders, a growing demand for minimally invasive procedures, and significant investments in Research & Development (R&D) activities.
Join us for an insightful podcast episode featuring Dennis Hursh, a veteran attorney with over 40 years of experience in health law. Discover the importance of letters of intent in physician contracts, their purpose, and the legal implications involved. Gain valuable advice on negotiating agreements and when to involve an attorney. Don’t miss this essential episode for physicians navigating employment contracts.
With the hashtag #GutTok clocking in more than 900 million views on TikTok as the beverage girlies incorporate prebiotic sodas into their sleepy girl mocktails and other users chomp on digestive-friendly snacks in between taking their supplements, interest in gut health has never been higher. The reason? Post-pandemic, consumers are increasingly more health-conscious, at the same time as digestive diseases are on the rise across the U.S., with the National Institutes of Health estimating that between 60 and 70 million Americans are affected.
Hydrogen-methane breath testing is valuable in clinical care for diagnosing small intestinal bacterial overgrowth (SIBO) and guiding treatment decisions. A recent paper by Tansel and Levinthal in Clinical and Translational Gastroenterology provides insights into the practical application of breath testing in real-world clinical scenarios, offering valuable information for gastroenterologists, dietitians, nutritionists, and other allied health providers.
Amazon’s telehealth expansion reportedly may be delayed, after Democratic lawmakers expressed their concerns about the service. According to an email from a person with direct knowledge about the service and obtained by Politico, Amazon Clinic will delay its launch of the expanded services by about three weeks. Politico reported Amazon was set to announce its expansion of Amazon Clinic to all 50 states Tuesday, but that promotional campaign was pushed back to July 19.
AbstractInflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn’s disease (CD), is a chronic, immune-mediated disorder that impacts the gastrointestinal tract. Significant advancements in the diagnosis and treatment of IBD have been made during the past few decades, improving patient outcomes. This narrative review aims to provide an overview of recent developments in the diagnosis and treatment of IBD. Both from an evaluative and therapeutic standpoint, the management of IBD has undergone significant change. The standard of treatment for treating UC and CD patients has changed due to several medical developments. These developments include amino-salicylates, immunosuppressants, biological agents, and…